Table 4 Literature review of the outcome studies regarding MT and VBG
Study, year of publication | Type IIIB and C / all tibial fractures | Bone defect (cm) mean (range) | Acute reconstruction/after nonunion | Union time (months) mean (range) | Major adverse outcome | Post-operative deep infection |
|---|---|---|---|---|---|---|
Masquelet technique | ||||||
Kang et al. [20] | 15/15 | 5.8 (4 – 11) | 15/0 | N/A (4–7) | 0 (0%) | 0 (0%) |
Sasaki et al. [28] | 1/5 | 4.9 (2.5 – 6) | 0/5 | 6 (4–9) | 0 (0%) | 1 (20%) |
Zoller et al. [19] | 3/8 | 6 (3 – 10) | 4/4 | 13.5 (1.8–27) | 4 (50%) | 5 (62.5%) |
Ma et al. [29] | 6/15 | 0.97 (0 – 3.5) | 0/15 | 7.5 (3–12) | 0 (0%) | 3 (20%) |
Cho et al. [30] | 8/11 | 7.52 (3.4–15.9) | 0/11 | 9.1 (6–12) | 2 (18.1%) | 0 (%) |
Giannoudis et al. [31] | 2/11 | 4.49 (3.5 – 7.5) | 4/7 | 5.7 (2–12) | 1 (9%) | 1 (9%) |
Gupta et al. [32] | 3/9 | 5.26 (3.3 – 8.5) | 0/9 | 10.5 (8–13) | 1 (11.1%) | 2 (22.2%) |
Vascularized bone graft | ||||||
Bibbo et al. [24] | 8/8 | 10.2 (8.9–12.6) | 8/0 | 9 (7–14) | 0 (0%) | 0 (0%) |
Cavadas et al. [22] | 41/41 | N/A (4 – 17) | 9/32 | N/A (5–9) | 0 (0%) | 2 (4.8%) |
Zhen et al. [23] | 28/28 | 15 (12 – 18) | 28/0 | 8 (6.5–10.3) | 0 (0%) | 0 (%) |